Skip to content
healthcare.dev

Giltuss EX Maximum Strength Expectorant

NDC 58552-341, Giltuss EX Maximum Strength Expectorant, tablet, from Gil Pharmaceutical Corp.

Product NDC
58552-341
Status
Listed
Labeler
Gil Pharmaceutical Corp
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58552-341 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
58552-341-07585520341071 BLISTER PACK in 1 CARTON (58552-341-07) / 7 TABLET in 1 BLISTER PACK
58552-341-14585520341141 BOTTLE in 1 CARTON (58552-341-14) / 14 TABLET in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58552-341 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58552-341 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58552-341. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.